N=1 Experiments: Understanding Self-Tracking

TL;DR: A clean N=1 observation has one variable, 2–4 weeks baseline, an observation phase of biologically adequate duration (2 weeks for sleep, 12 weeks for vitamin D serum levels), a washout for reversible changes and standardized measurements. Without baseline and washout, placebo and noise get measured. Without long phases, adaptation is captured instead of effect.

This article is purely informational and does not replace medical advice. Intake, dose and therapy of medications, dietary supplements or hormones should be clarified with a doctor; the dose set by the doctor is what counts. For peptides and unapproved substances, this article explicitly makes no recommendation for use.

What N=1 Really Means

N=1 means a single person is study lead, study participant and data analyst at the same time. One person, one concrete question, one structured observation. The method is a foundation of the self-tracking community, from cortisol measurements and CGM evaluations to sleep data. It is methodologically more demanding than is often assumed.

The goal is not to produce general conclusions but to place one’s own course of values reliably in context. A large study shows the average effect across many people. An N=1 evaluation shows how one’s own values behave.

An average from a study says nothing about how strong an effect is in an individual case: it can be larger, smaller or absent. Without methodology it stays at “I think it works,” and that is not a sound basis for health decisions. Those decisions are made together with a doctor.

Why Single Cases Deceive

Before any evaluation it is worth knowing the six classic error sources. Each one can simulate an effect that does not exist.

Regression to the mean. If an observation starts during a bad phase, the state will likely drift back toward average, regardless of any measure. That drift is then wrongly attributed to the measure.

Placebo effect. In pain, sleep and mood research, placebos account for 20 to 40 percent of measured effects. The expectation that something helps produces measurable biological changes.

Confirmation bias. Data that supports one’s own hypothesis stands out more. A good night’s sleep gets recorded; the bad night two days later gets forgotten or blamed on “too much coffee.”

Novelty effect. Anything new changes behavior and attention short-term. A new evening routine works for the first two weeks, then the effect often disappears.

Confounders. Season, training, sleep quality, work stress, alcohol, vacation, menstrual cycle. Each of these variables can influence outcome measures more than the observed change.

Measurement noise. Wearables typically have 5 to 15 percent deviation. Blood pressure varies 10 to 20 mmHg across a day. Blood glucose varies by time of day, meal and sleep. Single measurements are almost always misleading.

For deeper methodology on data quality, see the guide on wearable data quality.

Core Principles for Reliable N=1 Evaluations

Five principles turn a self-observation into an evaluation that supports a robust statement.

1. One Variable at a Time

Methodologically, several things should not change in parallel, such as a new training program and new sleep times together. Each change needs a complete phase before the next one starts. This is slow, but it is the only arrangement that supports causal reasoning. Changes to medication or dietary supplements do not belong in self-directed trials; they belong in consultation with a doctor.

2. Baseline Phase (2–4 Weeks)

Before any observation the current state is captured: subjective measures (sleep quality 1–10, energy 1–10) and objective ones (HRV, sleep duration, weight, blood values). At least 14 data points are usual, ideally 21. Without a baseline it is unclear what has actually changed. The biomarker baseline checklist offers orientation.

3. Observation Phase With Biologically Sensible Duration

The most common error is phases that are too short. Biological systems need time to adapt. An overview of typical periods in which outcome measures can change according to the research:

If an “effect” shows up after 10 days, it is almost always placebo or noise.

4. Washout Phase (for Reversible Changes)

After the observation phase come 2 to 4 weeks without the change. The question is whether outcomes return to baseline. If they do, that is a strong indication that the course was actually linked to the change. If not, either something else changed or the effect is not reversible (e.g. training adaptation).

5. Standardized Measurement

Same time, same conditions, same procedure. Specifically:

• HRV: morning, directly after waking, 5 minutes lying down, before drinking
• Blood pressure: 7-day average from two morning and two evening measurements
• Weight: morning fasted after bathroom, same scale
• Blood glucose (CGM): the fasting morning value as comparison
• Blood tests: same lab, same draw conditions (see blood draw)

Design Patterns for N=1

Three designs cover 90 percent of sensible self-observations.

A) ABA design (baseline → change → washout). The simplest pattern. It shows whether the outcome responds reversibly to the change. 4 to 12 weeks per phase. Suited to a first evaluation of a lifestyle change.

B) ABAB design (multiple alternation). The methodological gold standard for N=1. The cycle is repeated once, reducing the risk that a confounder explains the effect. If the outcome rises in both B phases and falls in both A phases, that is strong evidence. Total duration: 16 to 48 weeks.

C) Multiple crossover with blinded sequence. Known from clinical research: participants do not know the order of the phases. This eliminates placebo effects but takes more organization. For any substance it belongs in a medically or scientifically supervised setting, not in a self-experiment.

Four Examples of Measurement Designs

Example 1: Evening Routine and Sleep Quality

• Outcomes: Sleep score (wearable), deep sleep minutes, sleep onset time, subjective recovery (1–10)
• Baseline: 2 weeks unchanged
• Observation phase: 4 weeks with a changed evening routine
• Washout: 2 weeks back to the original routine
• Analysis: Mean ± standard deviation per phase, compare B vs. A1 and A2

Example 2: Coffee Cutoff

• Outcomes: Sleep onset time, nighttime HRV, wake after sleep onset (WASO)
• Question: Is a last coffee at 2 p.m. associated with different HRV values than at 6 p.m.?
• Design: 3 weeks 2 p.m. cutoff, 3 weeks 6 p.m. cutoff, repeat in reversed order
• Analysis: HRV mean per condition, difference as effect size

Example 3: Cortisol Over Time

• Outcomes: Morning serum cortisol (lab), diurnal saliva profile (4 time points), subjective stress (1–10)
• Baseline: Blood draw and saliva profile in week 0
• Follow-up: Blood draw and saliva profile in week 8
• Optional: Re-measure 4 weeks later
• Interpretation: Lab values are interpreted by a doctor

Example 4: CGM Evaluation With Meal Order

• Outcomes: Glucose peak, time in range (70–140 mg/dl), area under curve 2 h postprandial
• Question: Is the order vegetables → protein → carbs associated with a different glucose peak than the reversed order?
• Design: Same meal on 7 days in order A, 7 days in order B
• Analysis: Mean glucose peak A vs. B, standard deviation

This example shows: N=1 doesn’t always need weeks. For short-term outcomes like postprandial glucose, a day-by-day comparison is enough. More methodology is in the insight sprint method.

Statistical Evaluation

A degree in statistics is not needed to evaluate an N=1. Four tools cover almost all cases.

1. Mean and standard deviation per phase. For each phase (A1, B1, A2, B2), the average of the outcome and its standard deviation are calculated. A difference between two phases counts as meaningful when it exceeds twice the baseline standard deviation.

2. Visual inspection. A time-series plot with all data points and marked phase boundaries often shows trends before statistics does. A jump in the B phase and a drop in A2 is visually convincing.

3. Spearman rank correlation. It shows trends within a phase. If HRV rises continuously across weeks 1 to 4 of the B phase, there is a positive correlation between time and outcome.

4. t-test with enough data points. With more than 30 measurements per phase (typical for daily wearable data), a paired t-test can be run. P-values below 0.05 are a hint, but not strict proof in an N=1 context.

Important: significant statistics require many data points. Often a clean plot plus mean comparison is enough. Statistics should not be overdone.

Common Mistakes

Six mistakes appear in almost all beginners.

1. Observation phase too short. Drawing conclusions after 10 days, although vitamin D serum levels, for example, have not even reached half of the plateau yet.
2. Multiple changes at once. New habits, new training and new sleep times together. No conclusion possible.
3. Single measurements instead of weekly means. A single HRV value says nothing. The 7-day mean says a lot.
4. No washout. Without washout, placebo and novelty cannot be ruled out.
5. Subjective outcomes without blinding. Anyone who knows a measure is expected to help often feels better. This is a well-known expectation effect.
6. Social media hype as “evidence.” An Instagram before-and-after doesn’t replace an experiment. Many community N=1 are poorly documented and publication-biased.

For classifying combinations of several supplements and their interactions, see the guide on supplement stack iteration. The same applies there: intake and combinations should be clarified with a doctor.

Documentation

The best methodology is worthless without clean documentation. A log belongs to every N=1.

Usually recorded daily:

• Date and time of the observed change
• Complaints or side effects (GI issues, headaches, skin changes) that should be discussed with a doctor
• Context variables: sleep duration, training intensity (1–10), stress (1–10), alcohol (units)
• Special events (illness, travel, unusual stress)

Exportable data is mandatory. A CSV export from the tracking tool allows proper analysis later in spreadsheets or statistics software. lab2go supports this export for biomarkers and supplement logs. For long-term biomarker tracking, see the guide on long-term biomarker tracking.

Ethics and Safety

Not every self-observation is harmless. Four principles protect against unnecessary risk.

No risk experiments without medical supervision. Off-label medications, peptides, injectable compounds and hormone therapies (TRT, SERMs) belong in medical hands, even if they can be bought online. This article makes no recommendation for the use of such substances.

Define stop criteria in advance. At what value or symptom does one stop and seek medical advice? Examples of reasons for medical review: liver enzymes above twice the upper limit, blood pressure above 160/100, resting heart rate above 80 bpm, persistent headache over 3 days.

Baseline blood values before pharmacological measures. Liver, kidney, complete blood count, CRP, hormone status. Without this baseline it is not possible to tell whether a later abnormal value was already there. Whether and when they are taken is decided by the treating doctor.

Keep follow-up intervals. With risk-profile measures, checks every 4 to 8 weeks are usual, not only at the end, and belong in medical hands.

Community and Evidence Aggregation

Single N=1 are anecdotes. Many N=1 with clean methodology can become quasi-evidence. The Quantified Self movement and knowledge platforms like Examine.com collect such data.

Two warnings: publication bias exists in self-observation too. Who likes to publish that nothing changed for them? Positive results are shared more often. Second, social media hype does not replace scientific grounding. PubMed and Examine.com remain the better references for the state of research and expected effects.

A clean N=1 of one’s own is valuable, especially when null results are recorded as well. That nudges the community toward better methodology.

lab2go as an N=1 Platform

A clean N=1 evaluation needs four components: biomarker trends, supplement log, context values, correlations. lab2go covers biomarker trends, supplement log and context values; correlations you build yourself.

• Biomarker trends: Every blood test is stored over time. It is immediately visible how a value such as vitamin D develops across the phases.
• Supplement log: Entries with date and time, exportable as CSV.
• Context values: HRV, sleep, resting heart rate or training intensity can be entered manually as a daily value, on the same timeline as lab results.
• Checking correlations yourself: Look at the supplement log and the biomarker trend side by side and do the analysis yourself.

A look at the features or plans and pricing shows how self-observations can be structured. lab2go is a tracking tool and provides no medical assessment.

Conclusion: Three Building Blocks of a Clean N=1 Evaluation

1. One question. Not three. One lifestyle variable, one concrete outcome.
2. Three phases. Baseline 2–4 weeks, observation of biologically sensible duration, washout 2–4 weeks. Write down in advance what is measured and what counts as a hit.
3. Daily documentation. Date, context, CSV export at the end, compare means per phase.

The biomarker baseline checklist is a suitable entry point for data capture.

This article is purely informational and does not replace medical advice. Intake, dose and therapy should be clarified with a doctor; for pharmacological or invasive measures, always seek medical advice. For peptides and unapproved substances, no recommendation for use is made. Self-tracking complements medicine. It does not replace it.